(128 days)
Not Found
No
The description focuses on the mechanical function and design of a hemostasis valve and does not mention any computational or learning capabilities.
No.
The device's intended use is to maintain hemostasis, facilitate device introduction/withdrawal, and assist with guide wire manipulation during diagnostic and interventional procedures, all of which are supportive functions for other medical devices rather than directly treating a disease or condition.
No
Explanation: The device is described as a hemostasis valve intended to maintain hemostasis during the introduction/withdrawal and use of other diagnostic and interventional devices. It does not perform any diagnostic function itself.
No
The device description clearly describes a physical, mechanical device (hemostasis valve, insertion tool, torquer) with hardware components and performance testing related to physical properties (leak test, tensile test, sterilization, biocompatibility). There is no mention of software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is for maintaining hemostasis during the introduction/withdrawal and use of diagnostic and interventional devices. This describes a function performed on the patient during a medical procedure, not a test performed on a sample taken from the patient.
- Device Description: The description details a mechanical valve designed to control blood flow around inserted devices. This is a physical medical device, not a reagent, instrument, or system intended for the examination of specimens derived from the human body.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples, detecting analytes, or providing diagnostic information based on laboratory testing.
Therefore, the CoLign™ Hemostasis Valve is a medical device used in interventional procedures, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
CoLign™ Hemostasis Valve is intended to to maintain hemostasis during the The introduction/withdrawal and use of diagnostic and interventional devices up to an external diameter of 7 French or smaller.
The insertion tool facilitates introduction of the guide wire through the hemostasis valve.
The torque when inserted into the proximal end of the guide wire provides a handle for easier manipulation of the guide wire.
Product codes (comma separated list FDA assigned to the subject device)
DTL
Device Description
The CoLign Hemostasis Valve is a device that can be operated with only one hand through its special "push-pull" mechanism. In the pushed-down position, the valve is open for safe insertion and removal of devices. In the pulled-up position, the valve is closed and seals smoothly round the inserted devices. Once the valve is closed, devices can still be manipulated freely. CoLign eliminates the need for adjustment of the hemostasis valve by rotating during the procedure. The CoLign Hemostasis Valve is compatible with most interventional devices based on rapid exchanged and over-the-wire technology. There are three models of the CoLign Hemostasis Valve: the Standard CoLign , the CoLign 20,and the CoLign 50. The configuration of the sideport is the only difference among the three models. The sideport of the Standard CoLign ends in a male luer, while the sidearm of the CoLign 20/50 ends with a 20/50 cm extension tubing and 3-way stopcock.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The results of the performance testing have demonstrated of the CoLign™ Hemostasis Valve.
- Visual Inspection for Pouch Integrity.
- Pouch Peel Test.
- Leak Test without products inserted.
- Leak test with guide wire and hypo tube inserted.
- Pressure Resistance Test.
- Tensile test on assembly of PU tube/PC fitting.
- Product Stability (Shelf Life).
- Product Sterilization.
- Biocompatibility Testing (all the test met the requirements specified in ISO 10993).
- Hemolysis -
- Pyrogenicity ।
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.4290 Cardiopulmonary bypass adaptor, stopcock, manifold, or fitting.
(a)
Identification. A cardiopulmonary bypass adaptor, stopcock, manifold, or fitting is a device used in cardiovascular diagnostic, surgical, and therapeutic applications to interconnect tubing, catheters, or other devices.(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.
0
1 Submitter
Jilin Coronado Medical Ltd. 9 South-west Circle Road, Fengman Economic Development Zone Jilin City. China Tel: 86-432-63529555 Establishment Registration Number: 3009718176
Official contact: Ms Tianya Ma, Regulatory Affairs Tel: 86-432-63529555 ext 610 Fax: 86-432-63528222 Email: tyma@coronadomed.com
2 Device
AUG 2 8 2013
| Trade name: | CoLign™ Hemostasis Valve |
|---|---|
| Common Name: | Hemostatic Valve |
| Classification Name: | Cardiopulmonary Bypass Adaptor, Stopcock, Manifold or Fitting |
| Classification: | Class II |
| Regulation Number: | 870.4290 |
| Product code: | DTL |
3 Predicate Device
The predicate devices is used to determine the substantial equivalence between the CoLign Hemostasis Valve and the EasyPass" Y-connector Hemostatic Valve marketed by Millimed A/S( # K042060)
4 Device Description
The CoLign Hemostasis Valve is a device that can be operated with only one hand through its special "push-pull" mechanism. In the pushed-down position, the valve is open for safe insertion and removal of devices. In the pulled-up position, the valve is closed and seals smoothly round the inserted devices. Once the valve is closed, devices can still be manipulated freely. CoLign eliminates the need for adjustment of the hemostasis valve by rotating during the procedure. The CoLign Hemostasis Valve is compatible with most interventional devices based on rapid exchanged and over-the-wire technology. There are three models of the CoLign Hemostasis Valve: the Standard CoLign , the CoLign 20,and the CoLign 50. The configuration of the sideport is the only difference among the three models. The sideport of the Standard CoLign ends in a male luer, while the sidearm of the CoLign 20/50 ends with a 20/50 cm extension tubing and 3-way stopcock.
5 Intended Use
1
CoLign™ Hemostasis Valve is intended to to maintain hemostasis during the The introduction/withdrawal and use of diagnostic and interventional devices up to an external diameter of 7 French or smaller.
The insertion tool facilitates introduction of the guide wire through the hemostasis valve.
The torque when inserted into the proximal end of the guide wire provides a handle for easier manipulation of the guide wire.
6 Comparisons of Technological Characteristics
Comparing CoLign Hemostasis Valve with the predicate devices, it has shown that the technological characteristics of the CoLign Hemostasis Valve such as materials used, performance, and sterilization are identical or substantially equivalent to the currently marketed predicate device method.
| General Information | CoLign™ | EasyPass™ |
|---|---|---|
| Manufacturer | Jilin Coronado Medical Ltd | Millimed A/S |
| Intended Use | CoLign Hemostatic Valve is | |
| intended to maintain hemostasis | ||
| during the introduction, use and | ||
| withdrawal of diagnostic and | ||
| interventional devices that have an | ||
| outer diameter of 7 French or | ||
| smaller. | Same | |
| Operational Principle | Pull-push valve with one-hand | |
| operation | Pull-push valve opener enables | |
| single handed control | ||
| Sterilization Method | ETO | ETO |
| Sub-component function | ||
| design | CoLign™ | EasyPass™ |
| Y-hub | Main body of the product | Same |
| Bridge valve | Holding the silicone valve in place | Similar Design |
| Hemositatic valve | ||
| sandwich | Maintain sealing with or without | |
| products inserted through the valve | Similar Design | |
| Valve opener | Mechanic opening of the silicone | |
| valve, by pushing a hollow tube | ||
| through the valve | Same | |
| Extension-tube | Functions as an extension of the | |
| product to be connected with | ||
| additional accessories | Same |
2
| 3-Way Stopcock | Enabling joining of accessories to
the distal end of the PU-tube | Same |
|----------------------------------------------------|---------------------------------------------------------------------|---------------------------------------------------------------|
| Introducer Needle
(Accessory) | Ensure a safe passage of product
through the silicone valve | Same |
| Torquer Device
(Accessory) | Ensure better handling of guide
wires | Same |
| Specification comparison | CoLign™ | Eas Pass™ |
| Optimal inner lumen | 7 French
(2.33mm/0.092") | 7 French
(2.33mm/0.092") |
| Inner diameter of
narrowest portion | 7.2F/2.4mm/0.094" | 7.2F/2.4mm/0.094" |
| Diameter of device to
inserted | Maximum
7F/2.33MM/0.092"
Minimum
0.53F/0.17mm/0.007" | Maximum
7F/2.33MM/0.092"
Minimum
0.53F/0.17mm/0.007" |
| Pressure resistance with
catheter and guidewire | 8bar | 8bar |
| Pressure resistance
without device | 20bar | 21bar |
| Component material | CoLign™ | EasyPass™ |
| Valve Body | Poly carbonate | Poly carbonate |
| O-ring | Silicone | Silicone |
7 Performance Data
The results of the performance testing have demonstrated of the CoLign™ Hemostasis Valve.
- Visual Inspection for Pouch Integrity .
- Pouch Peel Test .
- Leak Test without products inserted .
- Leak test with guide wire and hypo tube inserted .
- Pressure Resistance Test .
- . Tensile test on assembly of PU tube/PC fitting
- Product Stability (Shelf Life) .
- Product Sterilization .
- Biocompatibility Testing (all the test met the requirements specified in ISO 10993) .
- Hemolysis -
- Pyrogenicity ।
- 8 Substantial Equivalent Based on Assessment of Non-Clinical Performance Data
The performance test data of the non-clinical tests supports the substantial equivalence between CoLign Hemostasis Valve and the predicate device mentioned immediately above.
3
の Conclusion
It can be concluded that the CoLign Hemostasis Valve has demonstrated the substantial equivalence to the predicate devices with respect to intended use, technological characteristics.
4
Image /page/4/Picture/0 description: The image shows the logo for the Department of Health & Human Services USA. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or bird in flight. The symbol is made up of three curved lines that represent the wings and body of the bird.
· Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MI) 20993-0002
August 28, 2013
Jilin Coronado Medical, Ltd. Ms. Nicole Ma Regulatory Specialist 9 South-west Ring Road Fengman Economic Development Zone Jilin City, China 132016
Re: K131124
Trade/Device Name: CoLign Hemostasis Valve Regulation Number: 21 CFR 870.4290 Regulation Name: Cardiopulmonary Bypass Adaptor, Stopcock, Manifold, or Fitting Regulatory Class: Class II Product Code: DTL Dated: May 27, 2013 Received: June 03, 2013
Dear Ms. Ma:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. However, we remind you that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must
5
Page 2 - Ms. Nicole Ma
comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
M. A. Ellison
for
Bram D. Zuckerman, MD Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
Annex 1- Indication for Use Statement
Ki31124 510(k) Number (if known): ___ Device
Name: CoLign™ Hemostasis Valve
CoLign™ The Hemostasis Valve is intended to to maintain hemostasis during the introduction/withdrawal and use of diagnostic and interventional devices up to an external diameter of 7 French or smaller.
The insertion tool facilitates introduction of the guide wire go through the hemostasis valve.
The torquer when inserted into the proximal end of the guide wire provides a handle for easier manipulation of the guide wire.
Prescription Use _____________________________________________________________________________________________________________________________________________________________ (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use_ (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
M